Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer.
Degeling, Koen; Schivo, Stefano; Mehra, Niven; Koffijberg, Hendrik; Langerak, Rom; de Bono, Johann S; IJzerman, Maarten J.
; 20(10): 1411-1419, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-29241901
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.
Integrative clinical genomics of advanced prostate cancer.
Aggressive variants of castration-resistant prostate cancer.
Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy.
Targeting molecular resistance in castration-resistant prostate cancer.
Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.
Using circulating tumor cells to inform on prostate cancer biology and clinical utility.
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial.
Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer.
Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.